Massera, D.
Xu, S.
Walker, M. D.
Valderrábano, R. J.
Mukamal, K. J.
Ix, J. H.
Siscovick, D. S.
Tracy, R. P.
Robbins, J. A.
Biggs, M. L.
Xue, X.
Kizer, J. R.
Funding for this research was provided by:
National Heart, Lung, and Blood Institute (HHSN268201200036C, HHSN268200800007C, HHSN268201800001C, N01HC55222, N01HC85079, N01HC85080, N01HC85081, N01HC85082, N01HC85083, N01HC85086, U01HL080295, U01HL130114, K24HL135413)
National Institute of Neurological Disorders and Stroke (N/A)
National Institute on Aging (R01AG023629)
Corlette Glorney Foundation and The New York Academy of Medicine (The Glorney-Raisbeck Fellowship Program)
Article History
Received: 27 January 2019
Accepted: 3 June 2019
First Online: 21 June 2019
Compliance with ethical standards
: All field centers and the CHS Coordinating Center received institutional review board approval for the study and participants gave informed consent.
: Jorge R. Kizer reports stock ownership in Amgen, Bristol-Myers Squibb, Gilead Sciences, Merck, Johnson and Johnson, and Pfizer. Daniele Massera, Shuo Xu, Marcella D. Walker, Rodrigo J. Valderrábano, Kenneth J. Mukamal, Joachim H. Ix, David S. Siscovick, Russell P. Tracy, John A. Robbins, Mary L. Biggs, and Xiaonan Xue declare that they have no conflict of interest.